Intellia Therapeutics
NTLA
NTLA
76 hedge funds and large institutions have $236M invested in Intellia Therapeutics in 2017 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
4.6% less ownership
Funds ownership: 51.07% → 46.47% (-4.6%)
20% less call options, than puts
Call options by funds: $478K | Put options by funds: $599K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
76
Holding in Top 10
1
Calls
$478K
Puts
$599K
Top Buyers
| 1 | +$13.3M | |
| 2 | +$4.66M | |
| 3 | +$1.35M | |
| 4 |
PC
Paulson & Co
New York
|
+$1.11M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$751K |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$9.86M | |
| 3 | -$7.8M | |
| 4 |
Millennium Management
New York
|
-$1.87M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.83M |